AQP4 and myeloid sarcoma: MOGAD is now recognized as a distinct disease entity with an immunopathogenesis that differs from both multiple sclerosis (MS) and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) [1].